| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 641,6 k € | +15.3% | 556,5 k € | +17.1% | 475,4 k € | +317.6% | -218,5 k € | -71.5% | -127,4 k € | |
| EBITDA | -396,2 k € | -43.5% | -276,1 k € | -14.1% | -242,0 k € | +52.8% | -512,7 k € | -199.1% | -171,4 k € | |
| Operating profit | -2,7 M € | -2.6% | -2,6 M € | -24.3% | -2,1 M € | -85.1% | -1,1 M € | -138.2% | -475,7 k € | |
| Profit/loss | -2,6 M € | -3.1% | -2,5 M € | -25.8% | -2,0 M € | -80.1% | -1,1 M € | -139.8% | -463,8 k € | |
| Equity | 6,3 M € | +61.4% | 3,9 M € | +173.7% | 1,4 M € | -58.4% | 3,4 M € | -24.5% | 4,5 M € | |
| Total assets | 7,2 M € | +67.9% | 4,3 M € | +33.0% | 3,2 M € | -12.8% | 3,7 M € | -19.7% | 4,6 M € | |
| Cash | 6,0 M € | +96.8% | 3,0 M € | +131.5% | 1,3 M € | -58.4% | 3,1 M € | -28.6% | 4,4 M € | |
| Debts | 917,5 k € | +132.1% | 395,2 k € | -78.1% | 1,8 M € | +546.2% | 279,8 k € | +259.0% | 78,0 k € | |
| Staff | 9,3 | 8,2 | 7,1 | 2,9 | 0,6 | |||||
Public limited company · Charleroi · incorporated on 05/02/2021 · 9,3 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+96.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
NEUVASQ BIOTECHNOLOGIES is a Public limited company incorporated in 2021. Its main activity is: Management consultancy activities. Its registered office is in Charleroi. It employs on average 9,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette